|
시장보고서
상품코드
2051403
불임 치료제 시장 : 약제 유형별, 투여 경로별, 성별별, 유통 채널별, 지역별Infertility Drugs Market, By Drug Type, By Route of Administration, By Gender, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
불임 치료제 시장은 2026년에 44억 7,000만 달러로 추정되고, 2033년까지 71억 8,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 7.0%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 44억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 7.00% | 2033년 시장 규모 예측 : | 71억 8,000만 달러 |
불임이란 일정 기간 동안 피임을 하지 않고 정기적으로 성관계를 해도 자연적으로 아이를 가질 수 없는 상태를 말합니다. 전 세계적으로 불임은 사회와 건강에 큰 영향을 미치는 널리 퍼져 있는 문제입니다. 세계 불임 치료제 시장의 성장은 남성과 여성 모두에서 불임 발생률이 증가함에 따라 주도되고 있습니다. 스트레스 증가, 생활습관 변화, 비만, 성병, 유전적 이상 등의 위험요인이 남녀 모두 불임의 유병률 증가에 기여하고 있습니다. 보조생식술 기술의 발전과 불임 치료 성공률의 향상은 불임으로 고통받는 수백만 부부에게 희망을 가져다주고 있습니다. 많은 제약회사들이 배란 장애, 호르몬 균형 장애, 기타 불임 관련 문제를 치료할 수 있는 다양한 불임 치료제를 제공합니다.
시장 역학
세계 불임 치료제 시장의 성장은 불임률 증가, 부인과 질환의 유병률 증가, 불임 및 치료 옵션에 대한 인식 증가, 의료 비용 증가, 불임 치료 절차의 기술 발전, 정부 및 기타 조직의 재정 지원 등의 요인에 의해 주도되고 있습니다. 그러나 불임 치료의 높은 비용, 불임 치료에 따른 합병증과 위험, 엄격한 규제 프레임워크, 일부 국가의 문화적, 사회적 장벽 등의 요인이 시장 성장을 저해할 수 있습니다. 개발도상국의 불임 치료 및 체외수정(IVF) 클리닉 증가는 유망한 성장 기회를 가져올 수 있습니다. 신흥 경제국에서는 의료관광 증가와 유리한 규제로 인해 큰 성장 잠재력을 가지고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 불임 치료제 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 불임 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 불임치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 불임 치료제 시장 : 약제 유형별, 2021년-2033년
제5장 세계의 불임 치료제 시장 : 투여 경로별, 2021년-2033년
제6장 세계의 불임 치료제 시장 : 성별, 2021년-2033년
제7장 세계의 불임 치료제 시장 : 유통 채널별, 2021년-2033년
제8장 세계의 불임 치료제 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
LSH 26.06.18Infertility Drugs Market is estimated to be valued at USD 4.47 Bn in 2026 and is expected to reach USD 7.18 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.47 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.00% | 2033 Value Projection: | USD 7.18 Bn |
Infertility refers to the inability to conceive a child naturally after a period of regular unprotected sexual intercourse. Globally, infertility is a widely prevalent issue with societal and health implications. Global infertility drugs market growth is driven by increasing incidence of infertility among both men and women. Risk factors like rising stress levels, lifestyle changes, obesity, sexually transmitted diseases, and genetic abnormalities have contributed to growing prevalence of both male and female infertility. Advancements in assisted reproductive technologies and increasing success rates of infertility treatment procedures have provided hope to millions of struggling couples. Several pharmaceutical companies offer a wide range of infertility medications that can treat ovulation disorders, hormonal imbalances, and other fertility-related issues.
Market Dynamics
Global infertility drugs market growth is driven by factors such as rising infertility rates, increasing prevalence of gynecological disorders, growing awareness about infertility and treatment options, rising healthcare expenditure, technological advancements in fertility treatment procedures, and the financial assistance provided by governments and other organizations. However, factors such as high cost of infertility treatment, complications and risk associated with infertility therapy, stringent regulatory framework, and cultural and social barriers in some nations can hamper the market growth. Growing number of fertility and IVF clinics across developing regions can offer lucrative growth opportunities. Emerging economies offer significant growth potential due to increasing medical tourism and favorable regulations.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global infertility drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Merck, Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbVie Inc., and MSD.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global infertility drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infertility drugs market.
Market Segmentation
- By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Clomiphene citrate
- Sex hormones
- Gonadotropins
- Bromocriptine
- Cabergoline
- Imipramine
- Letrozole
- Metformin
- By Gender (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Merck & Co., Inc.
- Ferring Pharmaceuticals
- Pharma Mar, S.A.
- Novartis AG
- Pfizer, Inc.
- Takeda Pharmaceutical Company Limited
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- LIVZON Pharmaceutical Group Inc.
- Fairfax EggBank, Inc.
- Genea Limited
- Cook Medical Inc.
- Vitrolife
- Thermo Fisher Scientific, Inc.
- CooperSurgical, Inc.
- Monash IVF Group
- Finox Biotech (Finox AG)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Gender
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Infertility Drugs Market, By Drug Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Clomiphene citrate
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Sex hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gonadotropins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bromocriptine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cabergoline
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Imipramine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Letrozole
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Metformin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Infertility Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Infertility Drugs Market, By Gender, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Male
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Female
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Infertility Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Infertility Drugs Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Gender, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ferring Pharmaceuticals
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharma Mar, S.A.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LIVZON Pharmaceutical Group Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fairfax EggBank, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Genea Limited
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cook Medical Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vitrolife
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CooperSurgical, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Monash IVF Group
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Finox Biotech (Finox AG)
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
